VJHemOnc is committed to improving our service to you

EBMT 2018 | Endothelial dysfunction in transplant: defibrotide for VOD

VJHemOnc is committed to improving our service to you

Paul Richardson

Speaking at the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, talks about the pooled analysis of the efficacy of defibrotide in adults with veno-occlusive disease (VOD).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter